News
The Role of Early Biomarker Testing in EGFR-Mutated NSCLC
1+ hour, 44+ min ago (129+ words) Cancer Network In this closing segment, Dr Alexander Spira and Dr Edward Kim reflect on key takeaways from the patient case discussions, with a focus on the importance of early and comprehensive biomarker testing in early-stage EGFR-mutated non'small cell lung…...
Managing EGFR-TKI Toxicities in Early-Stage EGFR-Mutated NSCLC
5+ hour, 46+ min ago (154+ words) Cancer Network In this segment, Dr Alexander Spira and Dr Edward Kim focus on the importance of adverse event management in patients receiving adjuvant EGFR tyrosine kinase inhibitors for early-stage EGFR-mutated non'small cell lung cancer (NSCLC) Kim discusses common toxicities…...
Surgical Considerations After Neoadjuvant Therapy in EGFR-Mutated NSCLC
1+ hour, 48+ min ago (144+ words) Cancer Network In this segment, Dr Alexander Spira and Dr Natalie Vokes explore the impact of neoadjuvant targeted therapy on surgical planning and outcomes in early-stage EGFR-mutated non'small cell lung cancer (NSCLC) Vokes provides a surgeon's perspective on how preoperative…...
Why m RNA Vaccines Change the Melanoma Game
3+ hour, 2+ min ago (119+ words) Jamin C. Morrison, MD, highlighted the importance of the development of m RNA vaccines in melanoma. He described how the availability of these vaccines is making a shift towards more personalized therapy possible. Morrison is head of the Division of Hematology…...
FDA Lifts Partial Clinical Hold on Lorigerlimab for Gynecologic Cancer
5+ hour, 28+ min ago (147+ words) The FDA has removed the partial clinical hold on the phase 2 LINNET study of lorigerlimab for patients with platinum-resistant ovarian cancer and clear cell gynecologic cancer. With the lifting of this partial clinical hold, new patients will be enrolled in…...
FDA Clears At-Home HPV Self-Collection Kit to Expand Cervical Cancer Screening Access
1+ hour ago (631+ words) Cancer Network The FDA has cleared the Onclarity HPV Self-Collection Kit and approved the BD Onclarity HPV Assay with extended genotyping for at-home use, as tools for cervical cancer screening, according to a news release from Waters Corporation. 1 The regulatory…...
FDA Grants ODD to Rhenium-186 Obisbemeda for Pediatric Malignant Glioma
1+ hour, 27+ min ago (586+ words) Cancer Network The FDA has granted orphan drug designation to rhenium-186 obisbemeda (Reyobiq; 186 RNL) for the treatment of patients with pediatric malignant gliomas, according to a news release from Plus Therapeutics. 1 The designation encompasses a broader scope than initially requested,…...
Novel Nanoparticle May Improve SOC in Stage III Unresectable NSCLC
5+ hour, 14+ min ago (172+ words) JNJ-1900 may avoid the main limitations observed with other radiosensitizers and radioprotectors, according to Benjamin Cooper, MD. According to Cooper, JNJ-1900 represents an opportunity to improve upon a standard of care that has seen limited progress within the last decade. He…...
Comparing HIFU To Surgery and SBRT in Localized Prostate Cancer
19+ hour, 48+ min ago (158+ words) High-intensity focused ultrasound (HIFU) may confer favorable safety outcomes compared with surgery or stereotactic body radiation therapy (SBRT). In an interview with Cancer Network, Mina Fam, MD, compared the adverse effect profile of HIFU with other standards in the localized…...
When to Opt for Focal vs Radical Interventions in Localized Prostate Cancer
22+ hour, 2+ min ago (256+ words) Cancer Network In an interview with Cancer Network, Mina Fam, MD, medical director of Urologic Oncology at Jersey Shore University Medical Center and of Robotic Surgery at Ocean University Medical Center, as well as a urologic oncologist in the Hackensack…...